vs

Side-by-side financial comparison of CrossAmerica Partners LP (CAPL) and CABOT CORP (CBT). Click either name above to swap in a different company.

CrossAmerica Partners LP is the larger business by last-quarter revenue ($866.3M vs $849.0M, roughly 1.0× CABOT CORP). CABOT CORP runs the higher net margin — 8.6% vs 1.2%, a 7.4% gap on every dollar of revenue. On growth, CrossAmerica Partners LP posted the faster year-over-year revenue change (-8.3% vs -11.1%). CABOT CORP produced more free cash flow last quarter ($57.0M vs $22.4M). Over the past eight quarters, CrossAmerica Partners LP's revenue compounded faster (-4.1% CAGR vs -8.7%).

TowerBrook Capital Partners, L.P. is an investment management firm headquartered in London and New York City. TowerBrook spun out of Soros Fund Management in 2005 and became known for acquiring majority stakes in companies such as Jimmy Choo. Managing $25+ billion in a number of private equity funds and structured opportunities funds, TowerBrook listed 110 investments on its website as of 2025.

Cabot Corporation is an American specialty chemicals and performance materials company headquartered in Boston, Massachusetts. The company operates in over 20 countries with 36 manufacturing plants, eight research and development facilities, and 28 sales offices.

CAPL vs CBT — Head-to-Head

Bigger by revenue
CAPL
CAPL
1.0× larger
CAPL
$866.3M
$849.0M
CBT
Growing faster (revenue YoY)
CAPL
CAPL
+2.8% gap
CAPL
-8.3%
-11.1%
CBT
Higher net margin
CBT
CBT
7.4% more per $
CBT
8.6%
1.2%
CAPL
More free cash flow
CBT
CBT
$34.6M more FCF
CBT
$57.0M
$22.4M
CAPL
Faster 2-yr revenue CAGR
CAPL
CAPL
Annualised
CAPL
-4.1%
-8.7%
CBT

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
CAPL
CAPL
CBT
CBT
Revenue
$866.3M
$849.0M
Net Profit
$10.2M
$73.0M
Gross Margin
12.4%
24.9%
Operating Margin
3.0%
15.2%
Net Margin
1.2%
8.6%
Revenue YoY
-8.3%
-11.1%
Net Profit YoY
-39.6%
-21.5%
EPS (diluted)
$0.24
$1.37

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CAPL
CAPL
CBT
CBT
Q4 25
$866.3M
$849.0M
Q3 25
$971.8M
$899.0M
Q2 25
$961.9M
$923.0M
Q1 25
$862.5M
$936.0M
Q4 24
$944.2M
$955.0M
Q3 24
$1.1B
$1.0B
Q2 24
$1.1B
$1.0B
Q1 24
$941.5M
$1.0B
Net Profit
CAPL
CAPL
CBT
CBT
Q4 25
$10.2M
$73.0M
Q3 25
$13.6M
$43.0M
Q2 25
$25.2M
$101.0M
Q1 25
$-7.1M
$94.0M
Q4 24
$16.9M
$93.0M
Q3 24
$10.7M
$137.0M
Q2 24
$12.4M
$109.0M
Q1 24
$-17.5M
$84.0M
Gross Margin
CAPL
CAPL
CBT
CBT
Q4 25
12.4%
24.9%
Q3 25
10.8%
24.5%
Q2 25
10.5%
26.4%
Q1 25
10.4%
25.7%
Q4 24
10.7%
24.6%
Q3 24
10.3%
24.0%
Q2 24
9.2%
25.2%
Q1 24
8.6%
24.1%
Operating Margin
CAPL
CAPL
CBT
CBT
Q4 25
3.0%
15.2%
Q3 25
2.9%
15.2%
Q2 25
4.3%
18.1%
Q1 25
0.2%
17.3%
Q4 24
3.0%
16.2%
Q3 24
2.5%
15.0%
Q2 24
2.5%
16.9%
Q1 24
-1.4%
15.3%
Net Margin
CAPL
CAPL
CBT
CBT
Q4 25
1.2%
8.6%
Q3 25
1.4%
4.8%
Q2 25
2.6%
10.9%
Q1 25
-0.8%
10.0%
Q4 24
1.8%
9.7%
Q3 24
1.0%
13.7%
Q2 24
1.1%
10.7%
Q1 24
-1.9%
8.2%
EPS (diluted)
CAPL
CAPL
CBT
CBT
Q4 25
$0.24
$1.37
Q3 25
$0.34
$0.80
Q2 25
$0.64
$1.86
Q1 25
$-0.20
$1.69
Q4 24
$0.42
$1.67
Q3 24
$0.27
$2.41
Q2 24
$0.31
$1.94
Q1 24
$-0.48
$1.49

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CAPL
CAPL
CBT
CBT
Cash + ST InvestmentsLiquidity on hand
$3.1M
$230.0M
Total DebtLower is stronger
$687.2M
Stockholders' EquityBook value
$1.6B
Total Assets
$964.7M
$3.8B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CAPL
CAPL
CBT
CBT
Q4 25
$3.1M
$230.0M
Q3 25
$5.8M
$258.0M
Q2 25
$9.7M
$239.0M
Q1 25
$6.7M
$213.0M
Q4 24
$3.4M
$183.0M
Q3 24
$7.8M
$223.0M
Q2 24
$5.5M
$197.0M
Q1 24
$6.3M
$206.0M
Total Debt
CAPL
CAPL
CBT
CBT
Q4 25
$687.2M
Q3 25
$700.8M
$1.1B
Q2 25
$722.7M
Q1 25
$774.1M
Q4 24
$763.9M
Q3 24
$769.2M
$1.1B
Q2 24
$786.7M
Q1 24
$795.8M
Stockholders' Equity
CAPL
CAPL
CBT
CBT
Q4 25
$1.6B
Q3 25
$1.6B
Q2 25
$1.5B
Q1 25
$1.4B
Q4 24
$1.4B
Q3 24
$1.4B
Q2 24
$1.3B
Q1 24
$1.4B
Total Assets
CAPL
CAPL
CBT
CBT
Q4 25
$964.7M
$3.8B
Q3 25
$998.9M
$3.8B
Q2 25
$1.0B
$3.8B
Q1 25
$1.1B
$3.8B
Q4 24
$1.1B
$3.6B
Q3 24
$1.1B
$3.7B
Q2 24
$1.2B
$3.6B
Q1 24
$1.2B
$3.6B
Debt / Equity
CAPL
CAPL
CBT
CBT
Q4 25
Q3 25
0.70×
Q2 25
Q1 25
Q4 24
Q3 24
0.75×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CAPL
CAPL
CBT
CBT
Operating Cash FlowLast quarter
$29.4M
$126.0M
Free Cash FlowOCF − Capex
$22.4M
$57.0M
FCF MarginFCF / Revenue
2.6%
6.7%
Capex IntensityCapex / Revenue
0.8%
8.1%
Cash ConversionOCF / Net Profit
2.89×
1.73×
TTM Free Cash FlowTrailing 4 quarters
$55.8M
$401.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CAPL
CAPL
CBT
CBT
Q4 25
$29.4M
$126.0M
Q3 25
$24.4M
$219.0M
Q2 25
$22.6M
$249.0M
Q1 25
$15.0M
$73.0M
Q4 24
$11.1M
$124.0M
Q3 24
$41.9M
$204.0M
Q2 24
$28.9M
$207.0M
Q1 24
$5.8M
$176.0M
Free Cash Flow
CAPL
CAPL
CBT
CBT
Q4 25
$22.4M
$57.0M
Q3 25
$17.7M
$155.0M
Q2 25
$10.8M
$188.0M
Q1 25
$4.9M
$1.0M
Q4 24
$3.9M
$47.0M
Q3 24
$34.2M
$112.0M
Q2 24
$23.6M
$155.0M
Q1 24
$-289.0K
$133.0M
FCF Margin
CAPL
CAPL
CBT
CBT
Q4 25
2.6%
6.7%
Q3 25
1.8%
17.2%
Q2 25
1.1%
20.4%
Q1 25
0.6%
0.1%
Q4 24
0.4%
4.9%
Q3 24
3.2%
11.2%
Q2 24
2.1%
15.3%
Q1 24
-0.0%
13.1%
Capex Intensity
CAPL
CAPL
CBT
CBT
Q4 25
0.8%
8.1%
Q3 25
0.7%
7.1%
Q2 25
1.2%
6.6%
Q1 25
1.2%
7.7%
Q4 24
0.8%
8.1%
Q3 24
0.7%
9.2%
Q2 24
0.5%
5.1%
Q1 24
0.6%
4.2%
Cash Conversion
CAPL
CAPL
CBT
CBT
Q4 25
2.89×
1.73×
Q3 25
1.79×
5.09×
Q2 25
0.90×
2.47×
Q1 25
0.78×
Q4 24
0.66×
1.33×
Q3 24
3.92×
1.49×
Q2 24
2.33×
1.90×
Q1 24
2.10×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CAPL
CAPL

Retail Segment$505.3M58%
Wholesale$360.9M42%
Other$1.2M0%

CBT
CBT

Reinforcement Materials$520.0M61%
Performance Chemicals$300.0M35%
Shipping And Handling$25.0M3%
Other Products And Services$4.0M0%

Related Comparisons